We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$12.9B
AUM Growth
+$12.9B
Cap. Flow
+$2.44B
Cap. Flow %
18.95%
Top 10 Hldgs %
13.49%
Holding
489
New
192
Increased
92
Reduced
78
Closed
35

Top Sells

Rank Stock Value
1
HQY icon
HealthEquity
HQY
+$34.8M
2
RCL icon
Royal Caribbean
RCL
+$33.2M
3
OMCL icon
Omnicell
OMCL
+$29.2M
4
TYL icon
Tyler Technologies
TYL
+$29.1M
5
CGNX icon
Cognex
CGNX
+$28.3M

Sector Composition

Rank Sector Weight
1 Healthcare 18.54%
2 Technology 17.46%
3 Industrials 16.92%
4 Consumer Discretionary 15.93%
5 Financials 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTWO icon
51
Take-Two Interactive
TTWO
$46.1B
$59.2M 0.46%
616,713
LLL
52
DELISTED
L3 Technologies, Inc.
LLL
$59M 0.46%
+28,350
New +$5.88M
LHX icon
53
L3Harris
LHX
$55.4B
$58.8M 0.46%
366,854
+218,102
+147% +$33.3M
PENN icon
54
PENN Entertainment
PENN
$2.84B
$58.4M 0.45%
2,322,613
+30,656
+1% +$886K
CSOD
55
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$57.5M 0.45%
1,481,811
QVCGA
56
DELISTED
QVC Group Inc Series A
QVCGA
$56.6M 0.44%
47,258
+6,983
+17% +$9.17M
TRU icon
57
TransUnion
TRU
$16B
$56.4M 0.44%
1,013,541
+134,977
+15% +$7.79M
ENTG icon
58
Entegris
ENTG
$16.3B
$56.3M 0.44%
1,683,299
AYI icon
59
Acuity Brands
AYI
$9.99B
$56.2M 0.44%
406,377
+18,980
+5% +$2.92M
VC icon
60
Visteon
VC
$2.85B
$56M 0.44%
516,321
+31,352
+6% +$3.92M
JBLU icon
61
JetBlue
JBLU
$2.16B
$54.3M 0.42%
2,751,539
TCBI icon
62
Texas Capital Bancshares
TCBI
$4.28B
$54.2M 0.42%
607,984
+132,248
+28% +$12.4M
BRKR icon
63
Bruker
BRKR
$9.4B
$54.2M 0.42%
+181,200
New +$5.88M
WWD icon
64
Woodward
WWD
$23B
$54.2M 0.42%
777,879
+270,731
+53% +$20.4M
TREE icon
65
LendingTree
TREE
$551M
$53.9M 0.42%
167,339
+75,530
+82% +$27.2M
IDXX icon
66
Idexx Laboratories
IDXX
$44.9B
$53.7M 0.42%
287,859
+39,473
+16% +$7.29M
HQY icon
67
HealthEquity
HQY
$8.71B
$53.5M 0.42%
88,325
-642,486
-88% -$34.8M
AMP icon
68
Ameriprise Financial
AMP
$47.8B
$53.4M 0.42%
374,563
+51,306
+16% +$8.37M
SHOO icon
69
Steven Madden
SHOO
$3.17B
$53.2M 0.41%
1,851,780
+114,183
+7% +$3.45M
ZTS icon
70
Zoetis
ZTS
$32.7B
$52.9M 0.41%
651,254
+44,670
+7% +$3.52M
ESGR
71
DELISTED
Enstar Group
ESGR
$51.2M 0.4%
244,572
GCO icon
72
Genesco
GCO
$434M
$51.1M 0.4%
1,304,280
-12,988
-1% -$482K
SBAC icon
73
SBA Communications
SBAC
$19.8B
$50.7M 0.39%
300,064
+38,054
+15% +$6.31M
CASY icon
74
Casey's General Stores
CASY
$32.1B
$50.7M 0.39%
464,214
+30,901
+7% +$3.58M
EW icon
75
Edwards Lifesciences
EW
$49.4B
$50.3M 0.39%
1,114,641
+121,809
+12% +$5.29M

Similar funds

Carillon Tower Advisers's Q1 2018 Portfolio in Review

As of Q1 2018, Carillon Tower Advisers held 489 positions worth $12.9B, up 136,756% from $9.4M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Carillon Tower Advisers deployed $2.44B of net new capital in Q1 2018, opening 192 new positions and adding to 92 existing holdings. Its largest new stake was Voya Financial: 871,250 shares worth $4.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was HealthEquity, an estimated $34.8M trimmed.

  • Carillon Tower Advisers's largest Q1 2018 buy was Voya Financial: 871,250 shares worth $4.4M.
  • Carillon Tower Advisers added most to DXC Technology in Q1 2018, an estimated $101M increase.
  • Carillon Tower Advisers's biggest Q1 2018 reduction was HealthEquity, cutting an estimated $34.8M.
  • Carillon Tower Advisers fully exited Prestige Consumer Healthcare in Q1 2018, selling an estimated $404K.
  • Carillon Tower Advisers's ten largest holdings make up 13% of its $12.9B portfolio in Q1 2018.
  • Carillon Tower Advisers opened 192 new positions and closed 35 in Q1 2018.
  • Carillon Tower Advisers's portfolio value rose 136,756% quarter-over-quarter to $12.9B.

Based on Carillon Tower Advisers's 13F filing for Q1 2018, filed 14 May 2018.